News & Comment
AIM-quoted gold and diamonds play BDI Mining says independent consultant WWW International has put a market value of $285 per carat on the first parcel of 3,285 carats from its Cempaka venture in Indonesia, an increase of 52 per cent on the $187 a carat price achieved three years ago when the company tendered 4,656 carats from bulk testing. Robert Tyerman reports.
Read
|
Recommendations
Global staffing software star Bond cheered investors with upbeat contract news over the festive period. The company offers investors good growth at an appealing valuation following recent share price weakness.
Read
Recruitment industry software venture Bond gathered further share price altitude on news that bmi has selected its online recruitment tracking and management system to support its recruitment push.
Read
Positive news flow continues apace at staffing software star Bond, which has hit the acquisition trail again, paying £2.68m of its own cash for competitor Strictly Education.
Read
Growth Company Investor’s recommendations have easily outperformed the overall AIM Index this past 12 months. Below, we highlight our successes (and failures) and also revisit every single stock and deliver our current investment view
Read
While it remains one of the most consistent software vendors on AIM (a trading blip several years ago notwithstanding), Bond International Software has attracted nothing more than a modest rating.
Read
Read
Read
Read
Read
Read
Read
Read
Read
Read
Read
Read
Read
Read
|
Sector Articles
If you can identify companies that are about to turn from loss into profit then you might enjoy superlative returns. It is difficult, but not impossible
Read
If you're still steering clear of technology stocks you're missing a trick because upbeat attitudes, improved results and a steady stream of IPOs are transforming the sector
Read
The dollar's slump has prompted a few AIM companies to go on a US spending spree
Read
With many companies witnessing an upturn in business, a profits deluge awaits the IT sector
Read
Biotech stocks continue to thrive on the junior market. The only problem is that their fancy valuations are often underpinned, not by earnings, but by investor hopes.
Read
Aim finally dragged itself over the six hundred-constituent mark in the second week of September, thanks in the main to a further flurry of Full List deserters. Among the latest to switch codes were leisure centre operator Reflex, industrial components distributor ISA and women's clothing retailer Jacques Vert. There was still the odd fundraising newcomer, however, with medical support services business Synergy Healthcare gleaning £8 million from a private placing and on-line bookmaker ukbetting, which raised £5.6 million on its departure from ENIC.
Read
AIM's charge towards the 600-member mark continued unabashed this month with ten new companies entering the fray. As of 30 June London's junior market was home to 575 businesses – 12 months ago that figure stood at 429.
Read
|
|
|
